期刊
BIOMEDICINES
卷 10, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines10010160
关键词
Gaucher's disease; glucocerebrosidase; genetics; Lewy body dementia; mutation; neuropathology; Parkinson's disease; sequencing
资金
- Iqbal Farrukh and Asad Jamal Fund [NIH-P30 AG066515, NIH-R01 AG060747]
This study investigates the clinical and neuropathologic features of patients with Lewy body spectrum disorder (LBSD) carrying a nonsense variant in the GBA gene. Through literature review and case analysis, it suggests a potential pathogenic role of the GBA p.R202X mutation in LBSD, demonstrating clinical and pathological heterogeneity.
We describe the clinical and neuropathologic features of patients with Lewy body spectrum disorder (LBSD) carrying a nonsense variant, c.604C>T; p.R202X, in the glucocerebrosidase 1 (GBA) gene. While this GBA variant is causative for Gaucher's disease, the pathogenic role of this mutation in LBSD is unclear. Detailed neuropathologic evaluation was performed for one index case and a structured literature review of other GBA p.R202X carriers was conducted. Through the systematic literature search, we identified three additional reported subjects carrying the same GBA mutation, including one Parkinson's disease (PD) patient with early disease onset, one case with neuropathologically-verified LBSD, and one unaffected relative of a Gaucher's disease patient. Among the affected subjects carrying the GBA p.R202X, all males were diagnosed with Lewy body dementia, while the two females presented as PD. The clinical penetrance of GBA p.R202X in LBSD patients and families argues strongly for a pathogenic role for this variant, although presenting with a striking phenotypic heterogeneity of clinical and pathological features.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据